Latest NHS audit shows promising HbA1c results in type 1 diabetes
New NHS figures show a ‘significant’ reduction in HbA1c amongst individuals with type 1 diabetes in England and Wales.
Data published by the National Diabetes Audit’s Report 1 – Care Processes and Treatment Targets’ report has revealed that the percentage of adults with type 1 diabetes now achieving a HbA1c of <58 mmol/mol is at a record high.
The average HbA1 value of people with type 1 diabetes in the National Diabetes Audit in mmol/mol was not published in these data releases, NHS Digital have reported.
Conducted by NHS digital and Diabetes UK, the National Diabetes Audit provides a comprehensive view of diabetes care in England and Wales and measures the effectives of diabetes healthcare against NICE clinical guidelines and NICE quality standards.
Additionally, it supports improvement in the quality of diabetes care by enabling participating NHS services and organisations to:
- Assess local practice against NICE guidelines,
- Compare their care and care outcomes with similar services and organisations,
- Identify gaps or shortfalls that are priorities for improvement,
- Recognise and share best practice and provide a comprehensive national picture of diabetes care and outcomes in England and Wales.
Professor Partha Kar, National Specialty Advisor, Diabetes with NHS England believes that technological advancements in diabetes care and greater availability of self-management tools has helped this positive outcome.
He said: “There is much more to do such as tackling variation amongst areas, yet it is wonderful to see a change at a national scale.
“Hopefully with the changing NICE guidelines on glucose monitoring as well as the closed loops review impending, further technology to enable self-management will further improve care.”
According to Professor Kar, 50% of people with type 1 diabetes in the UK are now using flash glucose monitoring.
The audit’s findings were from January 2020 to the end of March 2021.
To access the full report, click here.